Skip to Main Content

Author Details

Sara Cherry
University of Pennsylvania
1993
145
58
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37377442SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.mBio2023
37669225Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development.J Infect Dis2023
37667052SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).Nat Immunol2023
38014114Evolutionary arms race between SARS-CoV-2 and interferon signaling via dynamic interaction with autophagy.bioRxiv2023
37848036Serotonin reduction in post-acute sequelae of viral infection.Cell2023
37949067The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection.Mol Cell2023
37674858Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus.PNAS Nexus2023
37723351Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).Nat Immunol2023
37461472Single cell susceptibility to SARS-CoV-2 infection is driven by variable cell states.bioRxiv2023
35130559Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2.Nature2022
36595913Protocol to assess RNA-RNA interactions in situ using an RNA-proximity ligation assay.STAR Protoc2022
35904479Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer.Cancer Discov2022
36103854Gutcha: The microbiota drives tumor-induced mortality.Immunity2022
35962146Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents.Commun Biol2022
36060064<i>Leishmania amazonensis</i> sabotages host cell SUMOylation for intracellular survival.iScience2022
36167073The lncRNA ALPHA specifically targets chikungunya virus to control infection.Mol Cell2022
36093377TEMPOL inhibits SARS-CoV-2 replication and development of lung disease in the Syrian hamster model.iScience2022
33891389Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors.J Med Chem2022
34189531Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.bioRxiv2021
33655282Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition.medRxiv2021
33791710Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Dynamics Tracking.medRxiv2021
33876749Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia.Proc Natl Acad Sci U S A2021
33811811Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2.Cell Rep2021
33886614High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.PLoS One2021
33631096Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.Cell2021
35130722Subcellular Detection of SARS-CoV-2 RNA in Human Tissue Reveals Distinct Localization in Alveolar Type 2 Pneumocytes and Alveolar Macrophages.mBio2021
34965418Orally acquired cyclic dinucleotides drive dSTING-dependent antiviral immunity in enterocytes.Cell Rep2021
34383886Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking.Clin Chem2021
34401878Multiplexed detection of SARS-CoV-2 genomic and subgenomic RNA using <i>in situ</i> hybridization.bioRxiv2021
34593624Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition.Proc Natl Acad Sci U S A2021
34156146Lipid droplet screen in human hepatocytes identifies TRRAP as a regulator of cellular triglyceride metabolism.Clin Transl Sci2021
34013274Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents.bioRxiv2021
34010142Pharmacological activation of STING blocks SARS-CoV-2 infection.Sci Immunol2021
34087174Rising to the challenge of COVID-19: Working on SARS-CoV-2 during the pandemic.Mol Cell2021
34166398SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.PLoS One2021
34111271Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.J Infect Dis2021
32164844Using Diverse Model Systems to Define Intestinal Epithelial Defenses to Enteric Viral Infections.Cell Host Microbe2020
32033386DEAD-Box Helicases: Sensors, Regulators, and Effectors for Antiviral Defense.Viruses2020
32056841Drosophila melanogaster as a model for arbovirus infection of adult salivary glands.Virology2020
32075743An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis.Cell Host Microbe2020
33200143Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.medRxiv2020
33374822Beyond the Surface: Endocytosis of Mosquito-Borne Flaviviruses.Viruses2020
33109765DDX56 Binds to Chikungunya Virus RNA To Control Infection.mBio2020
33269701Viral-induced alternative splicing of host genes promotes influenza replication.Elife2020
32747477Alternative splicing and cancer: insights, opportunities, and challenges from an expanding view of the transcriptome.Genes Dev2020
32800296Editorial overview: Viruses in a changing world.Curr Opin Virol2020
32682290Deciphering flavivirus-host interactions using quantitative proteomics.Curr Opin Immunol2020
30817056Long noncoding RNAs and the regulation of innate immunity and host-virus interactions.J Leukoc Biol2019
30260713Zika virus infection activates sting-dependent antiviral autophagy in the Drosophila brain.Autophagy2019
31358986DNA mismatch repair is required for the host innate response and controls cellular fate after influenza virus infection.Nat Microbiol2019
  • 1 - 50 of 145

Recommended Authors

Sarah van Tol
University of Texas Medical Branch
Career Start Year 2017
Number of shared co-authors 6
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 13
Andreas S Puschnik
Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 5
Jessica Sook Yuin Ho
Icahn School of Medicine at Mount Sinai, Duke-NUS Medical School
Career Start Year 2012
Number of shared co-authors 3
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 7
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 12
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 4
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 15
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 3
Priya Luthra
Trudeau Institute
Career Start Year 2007
Number of shared co-authors 6
Courtney Wilkins
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2005
Number of shared co-authors 4
Ivan Marazzi
Center for Epigenetics and Metabolism, University of California irvine
Career Start Year 2004
Number of shared co-authors 10
Jan Rehwinkel
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 2004
Number of shared co-authors 3
Nolwenn Jouvenet
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 8
Paul D De Jesus
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 11
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 5
Shirit Einav
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 4
Sumit K Chanda
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 21
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Daisy W Leung
Washington University School of Medicine
Career Start Year 1999
Number of shared co-authors 9
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 13
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 9
Jan E Carette
Stanford University School of Medicine
Career Start Year 1996
Number of shared co-authors 9
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 17
Abraham L Brass
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 7
Alec J Hirsch
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1992
Number of shared co-authors 4
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 11
Raul Andino
University of California san francisco
Career Start Year 1981
Number of shared co-authors 13
Michael G Katze
University of Washington
Career Start Year 1978
Number of shared co-authors 11

Collaborators

Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Co-authored papers 12
Michael S Diamond
Washington University School of Medicine
Co-authored papers 5
Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers 5
Daniel J Rader
Co-authored papers 5
Norbert Perrimon
Co-authored papers 4
Anurag Verma
Corporal Michael J Crescenz VA Medical Center Philadelphia
Co-authored papers 4
Deirdre C Tatomer
University of Pennsylvania Perelman School of Medicine
Co-authored papers 3
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 3
Steven G Deeks
University of California san francisco
Co-authored papers 3
Nathan L Weinbren
Boston Children's Hospital
Co-authored papers 3
Frederic D Bushman
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Timothy J Henrich
University of California san francisco
Co-authored papers 3
Neal Silverman
Co-authored papers 3
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers 3
Nuala J Meyer
University of Pennsylvania Philadelphia
Co-authored papers 2
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 2
Karin Przyklenk
Co-authored papers 2
Jason E Gestwicki
Institute for Neurodegenerative Diseases, University of California San Francisco
Co-authored papers 2
Svetlana Dokudovskaya
CNRS UMR9018, Institut Gustave Roussy, Universite Paris-Saclay
Co-authored papers 2
Hirotaka Watada
Co-authored papers 2
Carlos L??pez-Ot??n
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers 2
Richard H Scheuermann
J. Craig Venter Institute
Co-authored papers 2
David Sulzer
New York State Psychiatric Institute, Research Foundation for Mental Hygiene
Co-authored papers 2
Holly Hammond
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 2
David M Sabatini
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology
Co-authored papers 2
J. Wade Harper
Harvard Medical School
Co-authored papers 2
Nikolai V Gorbunov
Armed Forces Radiobiology Research Institute
Co-authored papers 2
Juan Fueyo
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
Lawrence H Boise
Winship Cancer Institute, Emory University
Co-authored papers 2
Thomas J Begley
University at Albany
Co-authored papers 2
Release 1.2